Related Experiment Video
Updated: Sep 19, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
"Prime and pull" vaccination strategy for treatment of cervical pre-cancer: not quite ready for prime time
Katherine Cooke1, Deanna G K Teoh1
1Division of Gynecologic Oncology, Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN, USA.
No abstract available in PubMed .
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Preventive Healthcare Services
Tumor Immunotherapy
Cancer Prevention
Some...
Vaccinations
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...